TNFSF13 and Miyoshi myopathy: IL-6 stimulates the proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF) production, activating NF-kB/PI3K/AKT and MAPK pathways and thus promoting MM cell survival [62].